Cargando…
The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigate...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500034/ https://www.ncbi.nlm.nih.gov/pubmed/23166440 http://dx.doi.org/10.2147/IJN.S36571 |
_version_ | 1782250050075754496 |
---|---|
author | Frank, Kerstin J Westedt, Ulrich Rosenblatt, Karin M Hölig, Peter Rosenberg, Jörg Mägerlein, Markus Fricker, Gert Brandl, Martin |
author_facet | Frank, Kerstin J Westedt, Ulrich Rosenblatt, Karin M Hölig, Peter Rosenberg, Jörg Mägerlein, Markus Fricker, Gert Brandl, Martin |
author_sort | Frank, Kerstin J |
collection | PubMed |
description | Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigated the supramolecular and the nano/microparticulate structures that emerge spontaneously upon dispersion of an ASD in aqueous medium and elucidated their influence on solubility. The ASD, prepared by hot melt extrusion, contained the poorly soluble ABT-102 (solubility in buffer, 0.05 μg/mL), a hydrophilic polymer, and three surfactants. The apparent solubility of ABT-102 from the ASD-formulation was enhanced up to 200 times in comparison to crystalline ABT-102. At the same time, the molecular solubility, as assessed by inverse equilibrium dialysis, was enhanced two times. Asymmetrical flow field-flow fractionation in combination with a multiangle light-scattering detector, an ultraviolet detector, and a refractometer enabled us to separate and identify the various supramolecular assemblies that were present in the aqueous dispersions of the API-free ASD (placebo) and of binary/ternary blends of the ingredients. Thus, the supramolecular assemblies with a molar mass between 20,000 and 90,000 could be assigned to the polyvinylpyrrolidone/vinyl acetate 64, while two other kinds of assemblies were assigned to different surfactant assemblies (micelles). The amount of ABT-102 remaining associated with each of the assemblies upon fractionation was quantified offline with high-performance liquid chromatography–ultraviolet-visible. The polymeric and the micellar fraction contributed to the substantial increase in apparent solubility of ABT-102. Furthermore, a microparticulate fraction was isolated by centrifugation and analyzed by scanning electron microscopy, X-ray scattering, and infrared spectroscopy. The microparticles were found to be amorphous and to contain two of the surfactants besides ABT-102 as the main component. The amorphous microparticles are assumed to be the origin of the observed increase in molecular solubility (“true” supersaturation). |
format | Online Article Text |
id | pubmed-3500034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-35000342012-11-19 The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility Frank, Kerstin J Westedt, Ulrich Rosenblatt, Karin M Hölig, Peter Rosenberg, Jörg Mägerlein, Markus Fricker, Gert Brandl, Martin Int J Nanomedicine Original Research Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigated the supramolecular and the nano/microparticulate structures that emerge spontaneously upon dispersion of an ASD in aqueous medium and elucidated their influence on solubility. The ASD, prepared by hot melt extrusion, contained the poorly soluble ABT-102 (solubility in buffer, 0.05 μg/mL), a hydrophilic polymer, and three surfactants. The apparent solubility of ABT-102 from the ASD-formulation was enhanced up to 200 times in comparison to crystalline ABT-102. At the same time, the molecular solubility, as assessed by inverse equilibrium dialysis, was enhanced two times. Asymmetrical flow field-flow fractionation in combination with a multiangle light-scattering detector, an ultraviolet detector, and a refractometer enabled us to separate and identify the various supramolecular assemblies that were present in the aqueous dispersions of the API-free ASD (placebo) and of binary/ternary blends of the ingredients. Thus, the supramolecular assemblies with a molar mass between 20,000 and 90,000 could be assigned to the polyvinylpyrrolidone/vinyl acetate 64, while two other kinds of assemblies were assigned to different surfactant assemblies (micelles). The amount of ABT-102 remaining associated with each of the assemblies upon fractionation was quantified offline with high-performance liquid chromatography–ultraviolet-visible. The polymeric and the micellar fraction contributed to the substantial increase in apparent solubility of ABT-102. Furthermore, a microparticulate fraction was isolated by centrifugation and analyzed by scanning electron microscopy, X-ray scattering, and infrared spectroscopy. The microparticles were found to be amorphous and to contain two of the surfactants besides ABT-102 as the main component. The amorphous microparticles are assumed to be the origin of the observed increase in molecular solubility (“true” supersaturation). Dove Medical Press 2012 2012-11-12 /pmc/articles/PMC3500034/ /pubmed/23166440 http://dx.doi.org/10.2147/IJN.S36571 Text en © 2012 Frank et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Frank, Kerstin J Westedt, Ulrich Rosenblatt, Karin M Hölig, Peter Rosenberg, Jörg Mägerlein, Markus Fricker, Gert Brandl, Martin The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility |
title | The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility |
title_full | The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility |
title_fullStr | The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility |
title_full_unstemmed | The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility |
title_short | The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility |
title_sort | amorphous solid dispersion of the poorly soluble abt-102 forms nano/microparticulate structures in aqueous medium: impact on solubility |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500034/ https://www.ncbi.nlm.nih.gov/pubmed/23166440 http://dx.doi.org/10.2147/IJN.S36571 |
work_keys_str_mv | AT frankkerstinj theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT westedtulrich theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT rosenblattkarinm theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT holigpeter theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT rosenbergjorg theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT magerleinmarkus theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT frickergert theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT brandlmartin theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT frankkerstinj amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT westedtulrich amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT rosenblattkarinm amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT holigpeter amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT rosenbergjorg amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT magerleinmarkus amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT frickergert amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility AT brandlmartin amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility |